Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04744025 · ClinicalTrials.gov registry record · NA
Microfluidics Versus Gradient Centrifugation Effect on Euploidy Rates
A NA study of Infertility and Recurrent Pregnancy Loss, sponsored by Lawrence Engmann.
- Active
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT04744025: Active NA study of Infertility and Recurrent Pregnancy Loss, sponsored by Lawrence Engmann.
NCT04744025 is a NA study of Infertility and Recurrent Pregnancy Loss that is active but no longer recruiting, run by Lawrence Engmann. The registered enrollment target is 150 participants, below the 7,587-participant average among 74 other Infertility trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04744025, a NA study of Infertility and Recurrent Pregnancy Loss, is active but no longer recruiting, sponsored by Lawrence Engmann.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This research is being done to determine if using a microfluidics chamber, a device used to process sperm, will be effective in improving the rates of embryos with normal chromosomes (structures that carry genetic information) during in vitro fertilization (IVF) treatment. The investigators hypothesize that this device is effective at improving rates of normal chromosomes among embryos.
Primary Outcome
Rate of embryos with normal chromosomes in both groups
Conditions Studied
Interventions
- DEVICE Microfluidics chamber
- OTHER Density Gradient Centrifugation
Study Locations (1)
Connecticut
- The Center for Advanced Reproductive Services - Farmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2021-01-13 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
What the registry record for NCT04744025 still lists
NCT04744025 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 7,587-participant average among 74 other Infertility trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Infertility appearing as the primary indexed condition, and to 2 interventions - of which Microfluidics chamber is the first listed.
NCT04744025 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT04744025 about?
NCT04744025 is a clinical study titled "Microfluidics Versus Gradient Centrifugation Effect on Euploidy Rates". This research is being done to determine if using a microfluidics chamber, a device used to process sperm, will be effective in improving the rates of embryos with normal chromosomes (structures that carry genetic information) during in vitro fertilization (IVF) treatment. The investigators hypothes...
What is the current status of trial NCT04744025?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2021-01-13. Estimated completion is 2022-12-31.
What conditions does trial NCT04744025 study?
This clinical trial studies the following conditions: Infertility, Recurrent Pregnancy Loss.
What interventions are being tested in trial NCT04744025?
The interventions under investigation include: Microfluidics chamber (DEVICE), Density Gradient Centrifugation (OTHER).
Who is sponsoring clinical trial NCT04744025?
This trial is sponsored by Lawrence Engmann, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04744025 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04744025's enrollment target sits among peer trials
150 48th of 74 higher than 27 of 74 other Infertility trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infertility trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
-
Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield
RECRUITING · NA
-
Use of Artificial Intelligence for Clinical Assessment of Assisted Reproductive Techniques and IVF Outcomes
RECRUITING · NA
-
Testicular Tissue Cryopreservation in Children
RECRUITING · NA
-
Sex Selection of Human Spermatozoa
RECRUITING · NA
-
Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI